Abstract
Purpose Multi-echo gradient-echo (ME-GRE) imaging in the spinal cord is susceptible to breathing-induced B0 field fluctuations due to the proximity of the lungs, leading to ghosting artifacts. A navigator readout can be used to monitor the fluctuations; however, standard navigator processing often fails in the spinal cord. Here, we introduce navigator processing tailored specifically for spinal cord imaging.
Methods ME-GRE data covering all spinal cord regions were acquired in six healthy volunteers during free breathing at 3T. Centerline navigator readouts and respiratory belt recordings were collected during the acquisitions. The navigator processing included a Fast Fourier Transform and subsequent interval selection targeting the spinal cord, as well as SNR-weighted averaging over samples and coils on the complex data. Furthermore, a phase unwrapping algorithm making use of the belt recordings was developed. Imaging data were corrected by phase demodulation before image reconstruction.
Results B0 field fluctuations and ghosting artifacts were largest in the lower cervical and upper lumbosacral cord (∼5 Hz std), close to the edges of the lungs. Image reconstruction based on optimized navigator correction improved visual image quality and quantitative metrics (SNR, CNR, ghosting) in all regions of the spinal cord. The improvement was largest in regions with large field fluctuations (group-averaged increase in SNR/CNR of up to 29%/37% in single-echo images).
Conclusions Optimized navigator-based correction can reduce ghosting artifacts and increase SNR/CNR in anatomical ME-GRE of the spinal cord. The enhanced image quality and ease of implementation across sites makes the technique attractive for clinical and scientific applications.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study received funding from the Swiss National Science Foundation (SNSF) (33IC30_179644). Imaging was performed with the support of the Swiss Center for Musculoskeletal Imaging, SCMI, Balgrist Campus AG, Zürich.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Kantonale Ethikkommission Zürich, BASEC ID: 2019-00074 gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
